Amylin-based therapies are emerging as promising obesity medications. , Eloralintide is a novel, selective amylin receptor agonist in development for weight management, type 2 diabetes and more! , US$ 20.70 Min. order: 1 piece ★★★★★ 4.9 (74 reviews) Sold : Login>>
Eli Lilly Comes Out As ADA Winner (NYSE:LLY) US$ 22.01 Min. order: 1 piece ★★★★★ 4.5 (106 reviews) Sold : Login>>
Wholesale Copper Peptide (GHK-Cu) 2% Recovery Serum for your store US$ 26.04 Min. order: 1 piece ★★★★★ 4.0 (46 reviews) Sold : Login>>
Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept US$ 20.41 Min. order: 1 piece ★★★★★ 5.0 (82 reviews) Sold : Login>>